Insider: Torley Helen PRESIDENT AND CEO - HALOZYME THERAPEUTICS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 770,451 | 0 | 770,451 |
| Value | $49,694,089.50 | $0.00 | $49,694,089.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 7,329 | Direct | COM | $69.94 | $512,619.58 | 770,451 |
| 03/04/2026 | DDS | 2,671 | Direct | COM | $70.95 | $189,494.10 | 767,780 |
| 03/03/2026 | DDS | 13,481 | Direct | COM | $68.85 | $928,166.85 | 774,299 |
| 03/03/2026 | DDS | 6,519 | Direct | COM | $69.33 | $451,981.83 | 767,780 |
| 03/02/2026 | DDS | 4,100 | Direct | COM | $69.20 | $283,707.70 | 783,680 |
| 03/02/2026 | DDS | 15,322 | Direct | COM | $69.80 | $1,069,460.28 | 768,358 |
| 03/02/2026 | DDS | 578 | Direct | COM | $70.46 | $40,726.46 | 767,780 |
| 02/05/2026 | DDS | 5,376 | Direct | COM | $78.38 | $421,365.50 | 713,343 |
| 02/05/2026 | DDS | 4,624 | Direct | COM | $78.94 | $365,000.06 | 708,719 |
| 02/04/2026 | DDS | 10,100 | Direct | COM | $77.54 | $783,154.00 | 708,719 |
| 02/04/2026 | DDS | 9,900 | Direct | COM | $76.94 | $761,666.40 | 718,819 |
| 02/03/2026 | DDS | 2,551 | Direct | COM | $74.88 | $191,016.33 | 726,168 |
| 02/03/2026 | DDS | 9,659 | Direct | COM | $75.94 | $733,543.10 | 716,509 |
| 02/03/2026 | DDS | 7,790 | Direct | COM | $76.73 | $597,757.86 | 708,719 |
| 12/01/2025 | DDS | 10,406 | Direct | COM | $68.51 | $712,935.87 | 714,882 |
| 12/01/2025 | DDS | 5,402 | Direct | COM | $69.44 | $375,120.28 | 709,480 |
| 12/01/2025 | DDS | 500 | Direct | COM | $70.36 | $35,181.00 | 708,980 |
| 12/01/2025 | DDS | 261 | Direct | COM | $71.60 | $18,687.60 | 708,719 |
| 11/12/2025 | DDS | 6,784 | Direct | COM | $71.09 | $482,267.78 | 734,217 |
| 11/12/2025 | DDS | 12,718 | Direct | COM | $70.22 | $893,032.52 | 741,001 |
| 11/12/2025 | DDS | 498 | Direct | COM | $71.67 | $35,690.17 | 733,719 |
| 11/11/2025 | DDS | 4,500 | Direct | COM | $67.89 | $305,514.00 | 749,219 |
| 11/11/2025 | DDS | 4,000 | Direct | COM | $68.80 | $275,180.00 | 745,219 |
| 11/11/2025 | DDS | 11,500 | Direct | COM | $69.73 | $801,906.50 | 733,719 |
| 11/10/2025 | DDS | 19,900 | Direct | COM | $68.71 | $1,367,408.60 | 733,819 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research